Filter
Exclude
Time range
-
Near
Christophep_a
πŸ“ˆ US Stock Market WhatsApp Group πŸ‡ΊπŸ‡Έ If you haven't yet managed to earn $5,000 every two weeks, I recommend joining my team of US stock analysts for professional analysis and precise predictions. Group πŸ‘‰ wa.me/19292618960 $NVDA $TSLA $PLTR $META $AMD #Stocks $IMVT
41
moleculexx
πŸ”” SIGNAL REMINDER 🌱 $IMVT Β· Phase 2 β†’ Phase 3 LONG-term Β· conviction 75/100 Entry $33.43–$33.77 β†’ Target $44.35–$49.73 πŸ“Š Floating P&L: 15.42% ( $154.17) Immunovant's profile presents a compelling case for a long position over the next 42 calendar days. The clinical vector is exceptionally strong at 100/100, underpinned by 10 active clinical trials, suggesting robust development momentum. However, the capital and sentiment vectors are more muted, at 35/100 and 44/100 respectively, reflecting a dearth of recent insider activity and limited retail interest, alongside sparse publication activity. … ⚠ Not financial advice Β· @moleculexx #IMVT #Immunovant #Immunotherapy #Immunology #Phase3 #FDA #Catalyst #ScienceTwitter #LongTermInvesting #Biotech #Biopharma #BiotechStocks #Pharma #DrugDevelopment #ClinicalTrials #LifeSciences #Stocks #Investing #StockMarket #StocksToWatch
1
1
15
Tatted_Jass
I created a dedicated WhatsApp group for $BMPS $IMVT $ΞšΞ‘Ξ™ shareholders and active traders to connect, share insights, and get tI latest updates. For both new and experienced traders. group:πŸ”—wa.me/18452061829 Click this link or the link on my homepage to join
33
Market IQ retweeted
SteveDJacobs
Minervini "Trend Template" Screener πŸ“ˆ 48 Stocks $RVMD $WLY $UFPT $AMN $PRKS $BIOA $IMVT $KNSA $DAVE $SENEA $ACHC $FLYW $MIRM $ERAS $EAT $MAN $MRCY $OC $CLDX $DYN $UTI $AFRM $PACS $PGEN $RLAY $KTB $GLUE $ARGX $RSI $AMLX $RCUS $RHI $GKOS $SRRK $PVLA $UA $JBLU $UAA $ELVN $ATAI $SGHC $CMPS $ARWR $ELAN $BEAM $AXGN $ALGN $IOVA The market cap has been limited to $1B for liquidity purposes This screener is inspired by the eight criteria "Trend Template" described by the ever excellent Mark Minervini in his classic book "Trade Like a Stock Market Wizard"
3
7
49
5,999
Biotech_FC
Replying to @PersimmonTI
For me in no particular order $BBIO $CYTK $COGT $IMVT
3
1,119
AndrewGals59420
Stock Ideas in Healthcare and Biotech - $EOLS, $BEAM, $ARWR, $DTIL, $WRBY, $KYMR, $FTRE, $IMVT, $LBRX, $FENC lots of Cup and handles here, a HTF also. Lots of interesting stuff but I like $EOLS, $WRBY and $KYMR most facebook.com/share/p/1938AUd…
351
cjkb117
Delayed once again... Monthly Update (delta adjusted): ABVX 23.3% NKTR 18.0 VKTX 11.8 BBIO 8.8 CRVS 8.6 IMVT 7.3 OCUL 5.5 ARDX 5.0 PTGX 5.0 MSFT 4.8 CRM 4.2 PRTA 3.7 BHVN 3.0 QURE 2.4 PALI 2.0 SOFI 1.7 CYTK 1.6 CTMX 1.4 MUU 1.1 TENX 0.9 IVVD 0.5 IKT 0.4 CUE 0.4 PEPG 0.3 RVPH 0.1
1
492
bioinvestor24
$PFE is getting ridiculously cheap vs peers. I am talking in comparison to $MRK $GILD or even $JNJ …. Pfizer still has good assets and descent pipeline ( CDK4 inh , immunology , ADC). The deal with Innovent was very good and brings several ADC opportunities … Market is unhappy with its BD and how much it spent. Metsera was really bad not that it will not sell the drug($) and get some ROI, but due to lost bigger opportunity as Pfizer been shouting about obesity for years. Chatter about PFE interest in $ABVX probably real but how much Pfizer willing to pay for something with still some questions on safety ? Watch also $SYRE or $IMVT .. but these not selling cheap either. I honestly don’t see how MRK has better future vs Pfizer and how it deserves more than double valuation ?
My gut feeling we arrived to critical stage in $PFE story and will see either a shake up in management or unusual size deal to rebalance the MC stark inequity with peers ? Even $AMGN and $GILD are much larger than Pfizer now ? Probably the time to consider a long term position.
5
1
31
15,927
Sun Park retweeted
Andre_AGTC
A few stock sitting at 40 or close to that level $VKTX $COGT $IMVT $RAPP 40 is good launch pad Bios trading at 40 one year ago $PRAX 40->340 $RVMD 40->190 $MIRM 40 ->120 Let's revisit next year I bet most of them if not all will trade triple digit
3
1
37
3,649
Andre_AGTC
Mid'26 update after $NUVL & $VTYX BO $KRYS DEB $MDGL NASH $XENE FOS $AXSM ADA $PRAX ET $RVMD RASmuti $ABVX IBD $CORT PROC $TVTX IgAN $CTYK HCM $MIRM $SRRK $AMLS $COGT $NKTR $VKTX $CMPS $MLYS $BLTE $CRNX $ABEO $IMVT $PVLA $KYMR $INSM $VRDN $BBIO $MANE
End of 2025 update Top 10 15 $MDGL NASH $KRYS DEB $AXSM MDD ADA $XENE FOS $RVMD RASmuti $PRAX ET $ABVX IBD $BBIO ATTR $MIRM IBAT $CTYK oHCM $CRNX $SRRK $NKTR $NUVL $VKTX $IMVT $VTYX $CYBN $ABEO $BLTE $CPRX $ALNY $MLYS $VRDN $KYMR
5
47
9,028
Biotech_FC
In the biotech space I’m still most excited about early commercial and soon to be commercial companies. $CYTK $BBIO $COGT $CRNX I also really like $IMVT and $NKTR
1
536
Gary Thomson retweeted
i_Know_First
Best Stocks To Buy Based on a Self-learning Algorithm: Returns up to 18.46% in 7 Days #brbr #imvt #duol #bldr #kura #bro #mgni #mho #ge #vttl #stocks #stockmarket #stocktrading #investing
2
3
190